|[March 27, 2014]
BIO Announces Kay Holcombe to Join as Senior Vice President, Science Policy
WASHINGTON --(Business Wire)--
Today, the Biotechnology Industry Organization (BIO) announced that Kay
Holcombe will be joining staff as Senior Vice President, Science Policy.
"We are very fortunate to have Kay join the BIO team," said Jim
Greenwood, President and CEO of BIO. "In addition to her extraordinarily
substantive experience and knowledge based on a long and distinguished
career in Washington, Kay is well-known throughout the industry and will
be an excellent addition to our staff."
Holcombe comes to BIO from Sanofi, where she most recently served as
Vice President, FDA Alliances and Federal Agency Relations.
Prior to joining Sanofi, she served nine years as Vice President,
Government Relations and Senior Policy Advisor at Genzyme and eight
years as Executive Vice President of Policy at Directions Inc., a
government relations consulting firm, where she provided strategic
planning, legislative, regulatory and policy advice to a variety of
clients in the health care industry and academia. She was professional
health legislative staff and senior health policy advisor to the House
Commerce Committee (under Representative John Dingell) and health staff
to the Senate Labor and Human Resources Committees (under Senator Orrin
Hatch). She served as FDA Deputy Associate Commissioner for Legislative
Affairs, and has held multiple other legislative, policy, and science
positions in various public health agencies.
In these positions, she worked on the Hatch-Waxman amendments to the
Food, Drug, & Cosmetic Act, and has engaged in every reauthorization
cycle of the Prescription Drug User Fee Act. Kay helped represent
industry in negotiations that led to enactment of biosimilars
legislation as part of the Affordable Care Act, and serves as Secretary
of the Board of the Reagan-Udall Foundatin for the FDA.
She has also served as an advocate for patients, and in particular
patients with rare disorders. She serves as a Board member of the
National Capitol Chapter of the National Multiple Sclerosis Society and
The National Blood Clot Alliance.
Holcombe will join BIO in early April.
BIO is the world's largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention, the world's largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW
is BIO's blog chronicling "innovations transforming our world" and the
BIO Newsletter is the organization's bi-weekly email newsletter." Subscribe
to the BIO Newsletter.
Upcoming BIO Events
Asia International Conference
April 8-9, 2014
Congress on Industrial Biotechnology
May 12-15, 2014
June 23-26, 2014
San Diego, CA (News - Alert)
September 16-18, 2014
Sioux Falls, SD
[ Back To TMCnet.com's Homepage ]